{"id":15095,"date":"2026-08-14T19:26:23","date_gmt":"2026-08-14T19:26:23","guid":{"rendered":"https:\/\/medical-article.com\/?p=15095"},"modified":"2026-08-14T19:26:23","modified_gmt":"2026-08-14T19:26:23","slug":"bristol-myers-squibb-protein-degrader-wins-first-in-class-fda-nod-in-multiple-myeloma","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=15095","title":{"rendered":"Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2026\/08\/bristol-myers-squibb-cancer-multiple-myeloma-iberdomide-zenbexus-fda-approval-targeted-protein-degradation-bms-bmy\/\"><\/a><\/p>\n<p>Bristol Myers Squibb\u2019s Zenbexus is the first FDA-approved drug in a new class of cancer drugs called CELMoDs. The pharma company is positioning this molecule as a successor to its legacy products for multiple myeloma. <\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2026\/08\/bristol-myers-squibb-cancer-multiple-myeloma-iberdomide-zenbexus-fda-approval-targeted-protein-degradation-bms-bmy\/\">Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Bristol Myers Squibb\u2019s Zenbexus is the first FDA-approved drug in a new class of cancer drugs called CELMoDs. The pharma company is positioning this molecule as a successor to its legacy products for multiple myeloma. The post Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma appeared first on MedCity News.<\/p>\n","protected":false},"author":0,"featured_media":15096,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-15095","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/15095"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15095"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/15095\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/15096"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}